|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 375.00 DKK | +3.36% |
|
+2.80% | -47.59% |
| 03:14pm | Deutsche Bank Remains Cautious on Pharmaceutical Sector Ahead of Earnings Season | FW |
| 02:42pm | European shares mixed as Trump's tariff uncertainty weighs on markets | RE |
| Capitalization | 2.58TCr 405.17Cr 345.33Cr 322.79Cr 296.96Cr 552.97Cr 35TCr 621.98Cr 3.85TCr 1.47TCr 16TCr 1.52TCr 1.49TCr 59TCr | P/E ratio 2025 * |
4.66x | P/E ratio 2026 * | 46.8x |
|---|---|---|---|---|---|
| Enterprise value | 1.42TCr 222.78Cr 189.87Cr 177.48Cr 163.28Cr 304.04Cr 19TCr 341.99Cr 2.12TCr 806.79Cr 8.91TCr 835.51Cr 818.29Cr 32TCr | EV / Sales 2025 * |
1.69x | EV / Sales 2026 * | 3.22x |
| Free-Float |
99.18% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Zealand Pharma A/S
More recommendations
More press releases
More news
| 1 day | +3.34% | ||
| 1 week | +2.17% | ||
| Current month | +5.07% | ||
| 1 month | -25.01% | ||
| 3 months | -15.89% | ||
| 6 months | -48.24% | ||
| Current year | -47.91% |
| 1 week | 347.6 |  | 378 |
| 1 month | 347.6 | | 498.2 |
| Current year | 347.6 | | 808 |
| 1 year | 347.6 | | 972 |
| 3 years | 105 | | 972 |
| 5 years | 69.55 | | 972 |
| 10 years | 69.55 | | 972 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 30/03/2022 | |
| Director of Finance/CFO | - | 01/11/2022 | |
David M. Kendall
CTO | Chief Tech/Sci/R&D Officer | 63 | 02/06/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | - | |
Kirsten Drejer
BRD | Director/Board Member | 69 | 19/04/2018 |
| Director/Board Member | 66 | 04/04/2019 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.49% | +2.17% | -60.62% | +243.50% | 405.17Cr | ||
| -0.71% | -2.69% | +15.36% | +32.81% | 3.35TCr | ||
| -1.38% | +0.42% | +83.69% | -36.34% | 2.79TCr | ||
| +1.72% | +3.56% | +38.33% | -34.56% | 2.71TCr | ||
| -0.21% | -0.43% | +38.77% | +291.96% | 1.84TCr | ||
| -1.30% | +5.66% | +196.69% | +2,096.08% | 1.68TCr | ||
| +2.59% | +0.19% | +138.40% | -67.88% | 1.3TCr | ||
| -2.83% | +18.32% | +199.59% | +347.25% | 1.29TCr | ||
| +4.47% | +2.93% | -23.02% | -45.75% | 1.27TCr | ||
| -0.63% | +0.56% | +98.57% | +99.30% | 1.2TCr | ||
| Average | +0.54% | +2.61% | +72.58% | +292.64% | 1.78TCr | |
| Weighted average by Cap. | +0.14% | +1.87% | +72.51% | +252.01% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 837.39Cr 131.74Cr 112.28Cr 104.96Cr 97Cr 179.8Cr 11TCr 202.24Cr 1.25TCr 477.11Cr 5.27TCr 494.09Cr 483.91Cr 19TCr | 406.68Cr 64Cr 55Cr 51Cr 47Cr 87Cr 5.49TCr 98Cr 607.82Cr 231.71Cr 2.56TCr 239.96Cr 235.01Cr 9.33TCr |
| Net income | 556.03Cr 87Cr 75Cr 70Cr 64Cr 119.39Cr 7.5TCr 134.29Cr 831.05Cr 316.8Cr 3.5TCr 328.08Cr 321.32Cr 13TCr | 54Cr 8.5Cr 7.24Cr 6.77Cr 6.23Cr 12Cr 728.67Cr 13Cr 81Cr 31Cr 339.78Cr 32Cr 31Cr 1.24TCr |
| Net Debt | -1.16TCr -182.39Cr -155.45Cr -145.31Cr -133.68Cr -248.93Cr -16TCr -279.99Cr -1.73TCr -660.54Cr -7.29TCr -684.05Cr -669.95Cr -27TCr | -1.26TCr -198.83Cr -169.47Cr -158.4Cr -145.73Cr -271.36Cr -17TCr -305.23Cr -1.89TCr -720.08Cr -7.95TCr -745.7Cr -730.33Cr -29TCr |
More financial data
* Estimated data
Employees
385
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/25/08 | 375.00 kr | +3.36% | 4,74,219 |
| 07/25/07 | 362.80 kr | -3.25% | 2,71,840 |
| 04/25/04 | 375.00 kr | +3.25% | 4,91,806 |
| 03/25/03 | 363.20 kr | -0.33% | 3,25,501 |
| 02/25/02 | 364.40 kr | -0.11% | 6,44,411 |
Delayed Quote Nasdaq Copenhagen, July 08, 2025 at 07:38 pm IST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
362.80DKK
Average target price
862.80DKK
Spread / Average Target
+137.82%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ZEAL Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition